SARS-CoV-2 Peptide Library
To date, without any approved COVID-19 vaccine or therapies, the COVID-19 pandemic is likely to continue to threaten lives. To meet the increasing demand in COVID-19 research, GenScript’s PhD level scientists developed a series of SARS-CoV-2 Peptide Libraries based on GenScript's rich experience in peptide design and synthesis. These SARS-CoV-2 Peptide Libraries can be used for T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion and Cellular immune response.
You can find the peptide libraries as below, and more peptide services here.
|
Peptide Name |
Source |
Number of peptide |
Purity |
Sequence |
|
HCoV-229E Spike Glycoprotein |
Human coronavirus 229E (HCoV-229E) Spike
glycoprotein |
291 peptides (15mers with 11 aa overlap) |
Crude, ≥70% to ≥98% |
|
|
HCoV-OC43 Spike glycoprotein |
Human coronavirus OC43 (HCoV-OC43) Spike
glycoprotein |
336 peptides (15mers with 11 aa overlap) |
Crude, ≥70% to ≥98% |
|
|
SARS-CoV-2 ORF3a |
SARSr-CoV (Severe Acute Respiratory
Syndrome-related coronavirus 2) Protein 3a |
66 peptides (15mers with 11 aa overlap) |
Crude, ≥70% to ≥98% |
|
|
SARS-CoV-2 N |
SARSr-CoV (Severe Acute Respiratory
Syndrome-related coronavirus 2) Nucleoprotein |
102 peptides (15mers with 11 aa overlap) |
Crude, ≥70% to ≥98% |
|
|
SARS-CoV-2 ORF6 |
SARSr-CoV (Severe Acute Respiratory
Syndrome-related coronavirus 2) Non-structural protein 6 |
13 peptides (15mers with 11 aa overlap) |
Crude, ≥70% to ≥98% |
|
|
SARS-CoV-2 ORF7b |
SARSr-CoV (Severe Acute Respiratory
Syndrome-related coronavirus 2) Non-structural Protein 7b |
8 peptides (15mers with 11 aa overlap) |
Crude, ≥70% to ≥98% |
|
|
SARS-CoV-2 ORF7a |
SARSr-CoV (Severe Acute Respiratory
Syndrome-related coronavirus 2) Non-structural protein 7A |
28 peptides (15mers with 11 aa overlap) |
Crude, ≥70% to ≥98% |
|
| SARS-CoV-2 ORF8 | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Non-structural protein 8 | 28 peptides (15mers with 11 aa overlap) | Crude, ≥70% to ≥98% | |
| SARS-CoV-2 ORF10 | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) ORF10 Protein | 7 peptides (15mers with 11 aa overlap) | Crude, ≥70% to ≥98% | |
| SARS-CoV-2 ORF9B | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Protein 9b | 22 peptides (15mers with 11 aa overlap) | Crude, ≥70% to ≥98% | |
| SARS-CoV-2 Spike Glycoprotein) | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Spike glycoprotein | 316 peptides (15mers with 11 aa overlap) | Crude, ≥70% to ≥98% | |
| SARS-CoV-2 E | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Envelope small membrane protein | 16 peptides (15mers with 11 aa overlap) | Crude, ≥70% to ≥98% | |
| SARS-CoV-2 M | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Membrane protein | 53 peptides (15mers with 11 aa overlap) | Crude, ≥70% to ≥98% | |
| SARS-CoV-2 Y14 | SARSr-CoV (Severe Acute Respiratory Syndrome-related coronavirus 2) Uncharacterized protein 14 | 16 peptides (15mers with 11 aa overlap) | Crude, ≥70% to ≥98% |
- Like (12)
- Reply
-
Share
About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2024 MolecularCloud